Dr. Hiroshi Tanaka
Analyst Biography & Expertise
Dr. Hiroshi Tanaka brings 16 years of semiconductor R&D and foundry market research experience. Having worked closely with leading silicon foundries in Hsinchu and Tokyo, Dr. Tanaka evaluates extreme ultraviolet lithography (High-NA EUV), High-Bandwidth Memory (HBM3e/HBM4), Gate-All-Around (GAA) transistor scaling, and silicon photonics for AI supercomputing datacenters.
Core Industry Specializations
Published Executive Insights (3)
An examination of how transformer neural networks are reducing preclinical drug lead identification times from 4 years to 8 months, reshaping biopharma valuation models.
Analyzing High-NA EUV optics adoption, anamorphic magnification, and foundry capital expenditure requirements for sub-2nm silicon fabrication.
Modeling oral vs injectable peptide market share, cardiovascular outcome trials, and supply chain capacity expansion across North America and Europe.